Company Active LTD

Company profile

Brainomix Limited

AI-Powered Imaging Biomarkers for Better Treatment | Radiology AI

Brainomix has developed automated medical software for stroke image analysis, and lung diseases such as NSCLC and IPF. Our Radiology AI biomarkers enable precision medicine for better treatment.

CRN
07426406
Founded
2010
Age
15

Overview

Legal name
BRAINOMIX LIMITED
Region
South East England
Registered address
FIRST FLOOR SEACOURT TOWER
WEST WAY
OXFORD
UNITED KINGDOM
OX2 0JJ
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

24 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

02 Apr
2026

Accounts With Accounts Type Group

Accounts Awaiting analysis

AA | Transaction MzUxNDEzNjU4OWFkaXF6a2N4

Published 02 Apr 2026 15:33

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

10 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

03 Oct
2024

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzQzNzY4NjAzNGFkaXF6a2N4 | Paper/PDF filed

Published 04 Oct 2024 11:22

02 Nov
2010

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2012
Funded years
2012, 2013, 2015, 2019, 2024
Age at first award
1 years

Projects

2024 Collaborative R&D Lead participant

Remote stroke diagnosis and treatment platform (RESDAT)

1 Jan 2024 to 30 Jun 2025

Awarded
£398,747
Total cost £569,638

Rapid diagnosis and treatment of stroke is critical in improving outcomes for stroke, which is the leading cause of serious long-term disability globally. Stroke is the fourth largest cause of death in the UK and costs £25.6 billion annually. The most common type of stroke is a large vessel occlusion which is a clot lodged in a major artery in the brain. ...

2019 Collaborative R&D

National Consortium of Intelligent Medical Imaging (NCIMI)

1 Jan 2019 to 31 Mar 2023

Awarded
£0
Total cost £262,673

"We have formed a consortium of collaborating hospitals and commercial companies with public and patient involvement and input from charities to enable us to work with the public and the NHS to best develop and test the use of Artificial Intelligence programmes to improve health care. We are working with university academics and NHS hospitals across the c...

2015 Collaborative R&D Lead participant

Imaging software to quantify salvageable brain tissue to select stroke patients

1 Oct 2015 to 30 Sep 2017

Awarded
£633,553
Total cost £1,055,922

Worldwide annually, 13,000,000 patients suffer a stroke. Mechanical clot removal (endovascular treatment) is expected to increase from 1% to 10% of patients, as recent studies show it improves patient outcome. It costs up to £23,000 per patient, making patient selection crucial for its adoption. Brainomix has developed the medical imaging software, e-ASPE...

2013 Small Business Research Initiative Lead participant

Selection of ischemic stroke patients that would benefit from thrombolysis using an automated scoring system (e-ASPECTS) on computated tomography brain scans

1 Sep 2013 to 31 Mar 2015

Awarded
£819,400
Total cost £819,400

Stroke is the third cause of death and the first cause of adult disability in the UK. Each year, there are about 110,000 strokes in the UK, 1 million in the European Union and 15 million worldwide. For the NHS, the direct and indirect costs amount to £9 billion. The majority of strokes (~90%) are ischaemic and caused by an occlusion of a brain artery. The...

2012 Special Interest Group Lead participant

Selection of ischemic stroke patients that would benefit from thrombolysis using an automated scoring system (e-ASPECTS) on computated tomography brain scans

1 Sep 2012 to 28 Feb 2013

Awarded
£89,200
Total cost £89,200

Awaiting Public Project Summary

Product types

Collaborative R&D Small Business Research Initiative Special Interest Group